Sector Chart IMPACT Therapeutics, Inc

Stocks

7630

CNE100007LG4

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 04:08:14 2026-08-13 EDT			5-day change	1st Jan Change
12.11 ^HKD	-7.84%		-6.12%	-

07-31	IMPACT Therapeutics, Inc and Pharmanovia Enter Exclusive License Agreement For Senaparib In Europe, Middle East And North Africa, Australia And New Zealand	CI
07-27	IMPACT Therapeutics, Inc Announces IMP3201 As A Preclinical Candidate, A First-In-Class CEACAM5-Targeted Dual-Payload ADC	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
IMPACT THERAPEUTICS, INC	462M	-	-	-	-	-
LONZA GROUP AG	48.72B
REVOLUTION MEDICINES, INC.	43.99B	-	-	-	-	-
BEONE MEDICINES AG	40.82B
IQVIA HOLDINGS INC.	39.79B
CELLTRION, INC.	32.7B